17412-39-4 Usage
Heterocyclic compound
A compound containing a ring structure with both carbon and non-carbon atoms (in this case, nitrogen) This indicates the structure of 2,6-DIMETHYLIMIDAZO[1,2-B]PYRIDAZINE, which is composed of a fused pyridazine and imidazole ring system.
Fused pyridazine and imidazole ring system
The compound's structure consists of a pyridazine ring (a six-membered ring with four nitrogen atoms) fused to an imidazole ring (a five-membered ring with two nitrogen atoms) This describes the specific arrangement of atoms in the compound.
Potential applications in pharmaceutical research and drug development
Due to its unique structure and potential biological activities, 2,6-DIMETHYLIMIDAZO[1,2-B]PYRIDAZINE may be useful in the creation of new medications This highlights the possible uses of the compound in the field of medicine.
Building block in the synthesis of other organic compounds
The compound may be used as a starting material or intermediate in the creation of other organic compounds This suggests that 2,6-DIMETHYLIMIDAZO[1,2-B]PYRIDAZINE can be further modified or combined with other compounds to create new molecules.
Further research needed
More studies are required to fully understand the properties and potential uses of 2,6-DIMETHYLIMIDAZO[1,2-B]PYRIDAZINE This indicates that the compound's potential applications and characteristics are not yet fully explored and require additional investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 17412-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,1 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17412-39:
(7*1)+(6*7)+(5*4)+(4*1)+(3*2)+(2*3)+(1*9)=94
94 % 10 = 4
So 17412-39-4 is a valid CAS Registry Number.
17412-39-4Relevant articles and documents
HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY
-
Page/Page column 46; 47-48, (2021/02/26)
A compound of formula (I) useful in the treatment of a Pneumoviridae viral infection.
2,6-DIMETHYL-N-((PYRIDIN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N-[(PYRIDIN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS
-
Page/Page column 19, (2020/05/19)
The compound is useful in therapy, in particular as an antiviral agent, e.g. in the treatment of an RNA viral infection. A pharmaceutical composition comprising the compound.
IMIDAZOPYRIDAZINE COMPOUNDS
-
, (2008/06/13)
The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
